1 |
Von Ranke FM, Zanetti G, e Silva JL, et al. Tuberous sclerosis complex:state-of-the-art review with a focus on pulmonary involvement[J]. Lung, 2015, 193(5): 619-627.
|
2 |
Johnson S. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms[J]. Thorax,1999, 54(3): 254-264.
|
3 |
Franz DN, Brody A, Meyer C, et al. Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis[J]. Am J Respir Crit Care Med, 2001, 164(4): 661-668.
|
4 |
Urban T, Lazor R, Lacronique J, et al. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d′Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM "O" P) [J]. Medicine(Baltimore), 1999, 78(5): 321-337.
|
5 |
Johnson SR, Tattersfield AE. Decline in lung function in lymphangioleiomyomatosis:relation to menopause and progesterone treatment[J]. Am J Respir Crit Care Med, 1999, 160(2): 628-633.
|
6 |
Aubry MC, Myers JL, Ryu JH, et al. Pulmonary lymphangioleiomyomatosis in a man[J]. Am J Respir Crit Care Med, 2000, 162(2 Pt1): 749-752.
|
7 |
Schiavina M, Di Scioscio V, Contini P, et al. Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex[J]. Am J Respir Crit Care Med, 2007, 176(1): 96-98.
|
8 |
周鹏程,余薇,汪盛贤,等. 肺淋巴管肌瘤病的临床诊治探讨[J/CD]. 中华肺部疾病杂志(电子版), 2015, 8(6): 750-753.
|
9 |
Johnson SR, Cordier JF, Lazor R, et al. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis[J]. Eur Respir J, 2010, 35(1): 14-26.
|
10 |
Northrup H, Krueger DA, International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference[J]. Pediatr Neurol, 2013, 49(4): 243-254.
|
11 |
Henske EP, Jozwiak S, Kingswood JC, et al. Tuberous sclerosis complex[J]. Nature Rev Dis Primers, 2016, 2: 16035.
|
12 |
Henske EP, McCormack FX. Lymphangioleiomyomatosis-a wolf in sheep′s clothing[J]. J Clin Invest, 2012, 122(11): 3807-3816.
|
13 |
Adriaensen ME, Schaefer-Prokop CM, Duyndam DA, et al. Radio-logical evidence of lymphangioleiomyomatosis in female and male patients with tuberous sclerosis complex[J]. Clin Radiol, 2011, 66(7): 625-628.
|
14 |
Strizheva GD, Carsillo T, Kruger WD, et al. The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis[J]. Am J Respir Crit Care Med, 2001, 163(1): 253-258.
|
15 |
McCormack FX, Inoue Y, Moss J, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis[J]. N Engl J Med, 2011, 364(17): 1595-1606.
|
16 |
Logginidou H, Ao X, Russo I, et al. Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis[J]. Chest, 2000,117(1): 25-30.
|
17 |
Avila NA, Chen CC, Chu SC, et al. Pulmonary lymphangioleiomyomatosis:correlation of ventilation-perfusion scintigraphy, chest radiography, and CT with pulmonary function tests[J]. Radiology, 2000, 214(2): 441-446.
|
18 |
Chu SC, Horiba K, Usuki J, et al. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis[J]. Chest, 1999, 115(4): 1041-1052.
|
19 |
Harari S, Torre O, Cassandro R, et al. Bronchoscopic diagnosis of Langerhans cell histiocytosis and lymphangioleiomyomatosis[J]. Respir Med, 2012, 106(9): 1286-1292.
|
20 |
Carsillo T, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis[J]. Proc Natl Acad Sci USA, 2000, 97(11): 6085-6090.
|
21 |
Castro M, Shepherd CW, Gomez MR, et al. Pulmonary tuberous sclerosis[J]. Chest, 1995, 107(1): 189-195.
|
22 |
Moss J, Avila NA, Barnes PM, et al. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex[J]. Am J Respir Crit Care Med, 2001, 164(4): 669-671.
|
23 |
Seyama K, Kumasaka T, Souma S, et al. Vascular endothelial growth factor-D is increased in serum of patients with lymphangioleiomyomatosis[J]. Lymphat Res Biol, 2006, 4(3): 143-152.
|
24 |
Young LR, Inoue Y, McCormack FX. Diagnostic potential of serum VEGF-D for lymphangioleiomyomatosis[J]. N Engl J Med, 2008, 358(2): 199-200.
|
25 |
Juvet SC, McCormack FX, Kwiatkowski DJ, et al. Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans[J]. Am J Respir Cell Mol Biol, 2007, 36(4): 398-408.
|
26 |
Bissler JJ, McCormack FX, Young LR, et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis[J]. N Engl J Med, 2008, 358(2): 140-151.
|
27 |
Hayashi T, Kumasaka T, Mitani K, et al. Loss of heterozygosity on tuberous sclerosis complex genes in multifocal micronodular pneumocyte hyperplasia[J]. Mod Pathol, 2010, 23(9): 1251-1260.
|
28 |
Muir TE, Leslie KO, Popper H, et al. Micronodular pneumocyte hyperplasia[J]. Am J Surg Pathol, 1998, 22(4): 465-472.
|
29 |
Lantuejoul S, Ferretti G, Negoescu A, et al. Multifocal alveolar hyperplasia associated with lymphangioleiomyomatosis in tuberous sclerosis[J]. Histopathology, 1997, 30(6): 570-575.
|
30 |
刘杰,陈荣昌,钟南山,等. 肺淋巴管肌瘤病并肺母细胞瘤1例临床分析并文献复习[J]. 国际呼吸杂志,2014, 34(18): 1361-1366.
|